VaccTrain Next
Context Currently, only 3% of all global clinical trials are conducted in Africa, even though Africa accounts for 17% of the world’s population and has the greatest genetic diversity. This can significantly delay local access to new, urgently needed safe and efficacious vaccines and medicines. The follow-up project VaccTrain Next…